2020, Number 05
<< Back Next >>
MediSan 2020; 24 (05)
Echographic and tomographic correspondence in the diagnosis of bladder cancer
Martín RAM, Bolaños VS, Pereira MC, Musle AM, García FJD
Language: Spanish
References: 18
Page: 861-874
PDF size: 1079.45 Kb.
ABSTRACT
Introduction:
The effective and early diagnosis of vesical cancer is of extreme importance to achieve a potentially healing treatment and, with it, to elevate the survival in those affected.
Objective:
To describe the echographic and tomographic findings in patients with bladder malignancies.
Methods:
An observational, descriptive and cross-sectional study of 250 patients with confirmed diagnosis of vesical cancer was carried out to whom had been previously performed echography and tomography in the Imagenology Service of the Saturnino Lora Teaching Clinical-Surgical Provincial Hospital in Santiago de Cuba, from January, 2013 to December, 2017.
Results:
In the series men over 60 years were more frequent. When analyzing the echographic findings there was prevalence of the echogenic structure, as well as of the bigger than 3 cm and vascularized very well defined tumors, besides other characteristics as calcifications, necrosis, adenopathies and infiltration in close structures. In the tomography the mixed image, captant tumors and practically the same characteristics found in the echography were mostly observed, so that there was an almost absolute coincidence between both diagnostic means.
onclusions:
The echographic image of bladder cancer is echogenic and mixed in comparison with the tomographic image, what facilitates an unquestionable diagnosis of the disease; nevertheless, the tomography profiles the characteristics and the coherent details in correspondence with the findings contributed by other imaging techniques.
REFERENCES
American Cancer Society. Acerca del cáncer de vejiga. Atlanta: ACS; 2016 [citado 11/11/2018]. Disponible en: https://www.cancer.org/content/dam/CRC/PDF/Public/9039.00.pdf
Kavoussi LR, Torrence RJ, Gillen DP, M'Liss A, Hudson EO, Haaff SM, et al. Results of 6 weekly intravesical BCG instillations on the treatment of superficial bladder tumors. J Urol. 1988;139(5):935-40.
Comisión contra el Cáncer. Situación epidemiológica del Uruguay en relación al cáncer. Montevideo: CHLCC; 2020.
Cuba. Ministerio de Salud Pública, Dirección de Registros Médicos y Estadísticas de Salud. Anuario estadístico de salud 2017. La Habana: MINSAP; 2018.
Ratliff TL, Haaf EO, Catalona WJ. Interleukin-2 production during intravesical baccille Calmette-Guerin therapy for bladder cancer. Clin Inmunol Inmunopathol. 1986;40(2):375-9.
Lee SSY, Li J, Tai JN, Ratliff TL, Park K, Cheng JX. Avasimibe encapsulated in human serum albumin blocks cholesterol esterification for selective cancer treatment. ACS Nano. 2015;9(3):2420-32.
Motta-Ramírez GA, Hernández-Hernández A, Aguilar Colmenero J, German- Garrido CO, Aragón- Flores M, Garrido- Sánchez GA. Evaluación y Patrones de imagen de neoplasias del urotelio por tomografía computarizada por multidetector. Anales de Radiología México. 2018;17(4):259-79.
Ettinger DS. Non-Small Cell Lung Cancer. Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017 [citado 11/11/2018];15(4):504-35. Disponible en: https://jnccn.org/abstract/journals/jnccn/15/4/article-p504.pdf
Walsh PC, Retik AB, Stamey TA, Darracott VE. Campbell's. Urology. 8 ed. Philadelphia: WB Saunders; 2002. p. 2785-841.
Uson Calvo A. Tumores de riñón y de vejiga en la tercera edad. En: Ribera Casado JM. Patología nefrourológica en Geriatría. Madrid: Editores Médicos; 2014. p. 197-218.
GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1659-724.
Chavan S, Bray F, Lortet-Tieulent J, Goodman M, Jernal A. International variations in bladder cancer incidence and mortality. Eur Urol. 2014;66(1):59-73.
Ruiz de la Parte A, Cazorla A, Bouhajeb Y, Miguel MT, Sarasa JL. Tumor fibroso solitario. Revisión de 20 casos. Actas de la XXVII Reunión Anual SEAP; 30 Ene 2004; Madrid, España; Madrid: SEAP; 2004 [citado 11/11/2018]. Disponible en: http://www.seap.es/reuniones/2004/partesblandas.htm
Joe BN, Bolaris M, Horvai A, Yeh BM, Coakley FV, Meng MV. Solitary fibrous tumor of the male pelvis: finding sat CT with histopathologic correlation. Clin Imaging. 2008;32(5):403-6.
Rodríguez Luna JM, Mayayo Dehesa T, Burgos Revilla J, Escudero Barrilero A. Nuevo protocolo de estadiaje local en el carcinoma vesical. Correlación ultrasonográfica, citológica e histopatológica. Arch Esp Urol. 1990;43(Suppl 1):51-64.
Sierra Pérez L, Morales Yera RA, Ibáñez Carrillo E. Quimioterapia neoadyuvante con metotrexato, vinblastina, adriamicina y cisplatino en el tratamiento del carcinoma vesical irresecable. Medicent Electron. 2018;22(2):165-8.
De la Rosa-Cisneros AR, Viveros-Contreras C, Torres-Aguilar J, Hernández-León O, Arellano-Cuadros R, Martínez-Carrillo G. Experiencia en el tratamiento de cáncer vesical. Rev Mex Urol. 2015;75(2):58-63.
Téllez Bernal E, Fernández-Tamayo NM, Trejo-Rivas AA, González-Rodríguez RM, Aguilar-Jiménez C, Mendoza-López A. Incidencia de tumores malignos en pacientes adultos diagnosticados por primera vez en el hospital Instituto de Seguridad y Servicio Social al Servicio de los Trabajadores del Estado de Puebla en el año 2013. Gaceta Mexicana de Oncología. 2015;14(2):75-8.